A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins

Status:
Completed

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

PF-04950615 is a new investigational hypercholesterolemic agent that is being tested in this study to evaluate if it can lower LDL cholesterol.

Phase 2

Pfizer

Bococizumab